Etodolac and solid dispersion with β-cyclodextrin

Drug Development and Industrial Pharmacy

Volumn 23, Issue 11, 1997, Pages 1123-1129

  Milic Askrabic J ^a   Rajic D S ^b   Tasic Lj ^a   Djuric S ^a   Kasa P ^c   Pintye Hodi K ^c  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b MILITARY TECHNICAL INSTITUTE   (Serbia)

^c UNIVERSITY OF SZEGED   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CYCLODEXTRIN; ETODOLAC; KLEPTOSE; UNCLASSIFIED DRUG;

ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DISSOLUTION; DRUG MIXTURE; DRUG SOLUBILITY; SCANNING ELECTRON MICROSCOPY; X RAY DIFFRACTION;

EID: 17144434476     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.3109/03639049709150503     Document Type: Article

References (11)

1. J. A. Balfour and M. M-T. Buckley, Drugs, 42, 274- 299 (1991).
2. K. Inoue, H. Fujisawa, A. Motonaga, Y. Inoue, T. Kyoi, F. Ueda, and K. Kimura, Biol. Pharm. Bull., 17, 1577-1583 (1994).
3. G. Puglisi, C. A. Ventura, A. Spadaro, G. Campana, and S. Spampinato, J. Pharm. Pharmacol., 47, 120-123 (1995).
4. S. Z. Lin, D. Wouessidjewe, M. C. Poelman, and D. Duchene, Int. J. Pharm. 69, 211-219 (1991).
5. B. Cappello, F. Barbato, M. I. La Rotonda and A. Miro, in "Proc. 1st World Meeting APGI/APV," Budapest, 9-11 May 1995, pp. 589-590.
6. T. Higuchi and K. A. Connors, Phase solubility techniques, in Adv. Anal. Chem. Instr., Interscience, New York, 1965, pp. 117-212.
7. Merck Index, XI Ed., Merck & Co. Inc., New York, 1993.
8. M. Guyot, F. Fawaz, J. Bildet, F. Bonini, and A. M. Lagueny, Int. J. Pharm. 123, 53-63 (1995).
9. M. A. Pena, C. Tros de Ylarduya, C. Martínez-Ohárriz, M. M. Gōni, C. Martin and M. Sánchez, in "Proc. 1st World Meeting APGI/APV," Budapest, 9-11 May 1995, pp. 597-598.
10. Y. Yazan and M. Summi, STP Pharm. Sci., 4, 128 (1994).
11. K. D. Rainsford, Drug Invest., 2 (Suppl. 4), 3-10 (1990).